FDA Brief

Warning letters Drugs

FDA warning letter to

Fancy Drops Beauty LLC

High riskIssued Oct 24, 2024Posted Nov 5, 2024Center for Drug Evaluation and Research (CDER)

FDA says Fancy Drops Beauty sells unapproved eye drops claimed to change eye color.

What happened

In July 2024, FDA reviewed the Fancy Drops Beauty website and found it offered Fancy Drops Color Changing Solutions Eye Drops in multiple colors for sale in the United States. The website claims said the drops lighten and brighten eye color, change eye color, and inhibit melanin and tyrosinase. FDA determined the products are unapproved new drugs and that no FDA-approved application is in effect for them.

What FDA found

  1. The eye drops are drugs because the website claims they change eye color and affect pigment production.

    FD&C Act section 201(g)(1), 21 U.S.C. 321(g)(1)
  2. The products are new drugs because they are not generally recognized as safe and effective for those uses.

    FD&C Act section 201(p), 21 U.S.C. 321(p)
  3. The products were offered for sale in interstate commerce without an FDA-approved application.

    FD&C Act sections 505(a) and 301(d), 21 U.S.C. 355(a) and 331(d)

What FDA wants

FDA asks the company to notify it in writing within 15 working days of steps taken to correct the violations, explain how recurrence will be prevented, and include supporting documents; if it disagrees, it must give reasoning and evidence.

Who should pay attention

  • consumers considering eye-color-changing drops
  • retailers and online marketplaces selling eye drops
  • brands or importers of ophthalmic products with drug-like claims

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. Natuzem

    FDA warned Mexico-based Natuzem for selling unapproved new drugs, including Reumofan Plus, to U.S. consumers online.

    High risk
  2. RonanRx, Inc. dba RonanRx

    FDA says RonanRx's website and X posts misbrand compounded semaglutide and tirzepatide with false or misleading claims.

    Low
  3. Calibrate IV Hydration

    FDA told Calibrate IV Hydration its umbilical cord and exosome IV products are unapproved drugs and unlicensed biologics.

    High risk
  4. Best Chinese Medicines LLC

    FDA warned Best Chinese Medicines LLC that five herbal products sold online are unapproved new drugs because their labeling claims to treat diseases.

    High risk